Clinical

Dataset Information

1

TR study of ‘multicenter Phase II study to evaluate efficacy and safety of combination therapy with trastuzumab and pertuzumab in patients with HER2-positive metastatic colorectal cancer"


ABSTRACT: Primary outcome(s): Cancer-related gene alteration, expression of protein, and expression of RNA

DISEASE(S): Colorectal Cancer

PROVIDER: 2645675 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| S-EPMC5584549 | biostudies-literature
| S-EPMC5538020 | biostudies-literature
| S-EPMC6493747 | biostudies-literature
| S-EPMC8748500 | biostudies-literature